MedTrace Logo

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

NCT03277469 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2026-04-22

No results posted yet for this study

Summary

The aim of this study is to develop new tools using magnetic resonance imaging (MRI) that will improve the brachytherapy procedure and treatment for participants with gynecologic cancer.

Conditions

  • Gynecologic Cancer

Interventions

DEVICE

MRI

Medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body

RADIATION

Brachytherapy

Radiation therapy that is delivered by inserting radioactive sources directly into a tumor

DEVICE

MRI Tracker

The MR tracking device consists of a series of radiofrequency (RF) microcoils that are embedded into brachytherapy catheter stylet. The RF microcoils allows for accurate spatial localization of an individual brachytherapy catheter.

Sponsors & Collaborators

Principal Investigators

  • Martin King, MD, PhD · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-13
Primary Completion
2026-12-15
Completion
2027-09-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03277469 on ClinicalTrials.gov